乳腺放射科运营的主动当日项目在未患病女性中识别致病性乳腺癌突变
该研究评估乳腺影像中心当日开展风险评估与基因检测的可行性:3345名女性完成问卷,1080名(32.3%)符合基因检测标准,416名完成检测,38名(9.1%)检出致病性突变。结论认为影像中心可运营此类项目,识别常规风险评估可能漏诊的高危女性。
要点
- 乳腺影像中心可当日完成风险评估与唾液基因检测,43.3%符合标准者提交样本。
- 完成检测者中9.1%检出致病性突变,26.2%为意义未明变异。
- 致病性突变者中34.2%在本机构采取了风险降低策略。
核心结论
- 乳腺影像中心能够运营当日癌症风险评估与基因检测项目,识别常规风险评估方法可能未诊断的高危女性,为放射科癌症照护增加传统影像服务之外的价值。
研究设计与样本
- 项目为综合评估、风险与教育项目,2019年6月5日启动,数据追踪至2020年7月22日;接受乳腺影像的女性完成问卷,以Tyrer-Cuzick风险及美国国家综合癌症网络标准评估基因检测资格,合格者当日接受检测前咨询并采集唾液,样本用34个多基因 panel 检测,总结统计量。
诊断标准与关键数值
- 共3345名女性完成问卷,1080名(32.3%)符合基因检测标准;468/1080(43.3%)提交基因样本,416/1080(38.5%)完成检测;416例完成检测中269例(64.7%)阴性、109例(26.2%)意义未明变异、38例(9.1%)诊断致病性突变;38例致病性突变中13例(34.2%)在本机构采取风险降低策略。
临床应用与阅片要点
- 作者认为这些主动项目为放射科癌症照护增加传统影像服务之外的价值,可识别常规风险评估方法可能未诊断的高危女性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: Pathogenic mutations in some genes elevate women's breast cancer risk, necessitating risk-reduction strategies. Unfortunately, women are underscreened for cancer risk, and when identified as potentially high risk, women seldom pursue genetic counseling or testing. To improve cancer risk management, this project determined the feasibility of radiology-operated, proactive, same-day risk assessment and genetic testing programs to diagnose high-risk women undergoing breast imaging.
MATERIALS AND METHODS: The Comprehensive Assessment, Risk & Education Program launched on June 5, 2019. Data was tracked through July 22, 2020. Women undergoing breast imaging completed questionnaires that calculated Tyrer-Cuzick risk and assessed genetic testing eligibility using National Comprehensive Cancer Network criteria. To encourage eligible women's genetic testing adherence, pretest counseling and saliva sample collection occurred that same day in the imaging center. Samples were tested by a 34-multigene panel. Genetic counselors called women with positive results. Women with negative results or variants of uncertain significance were mailed notifications. Summary statistics were calculated.
RESULTS: A total of 3345 women completed questionnaires. 1080 (32.3%) met genetic testing criteria. 468/1080 (43.3%) submitted genetic samples, and 416/1080 (38.5%) completed testing. Of 416 completed tests, 269 (64.7%) tested negative, 109 (26.2%) had variants of uncertain significance, and 38 (9.1%) diagnosed pathogenic mutations. 13/38 (34.2%) women with pathogenic mutations implemented risk-reduction strategies at our institution.
CONCLUSION: Breast imaging centers can operate same-day cancer risk assessment and genetic testing programs, identifying high-risk women that conventional risk assessment methods may not have diagnosed. These proactive programs add value to radiology departments' cancer care beyond traditional imaging services.
引用
- Loving VA, Luiten RC, Siettmann JM, et al. A Breast Radiology Department-operated, Proactive Same-day Program Identifies Pathogenic Breast Cancer Mutations in Unaffected Women. Acad Radiol. 2020. PMID: 33339730. doi:10.1016/j.acra.2020.12.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。